Moreover, the in vivo implantation of B16 and LLC cell lines into syngeneic mice also decreases Mettl-3 expression in tumor associated macrophages (TAM: CD11b+F4/80+), suggesting the loss of Mettl-3 in promoting tumor growth and thus survival defect. This evidence concerns the gene ITGAM and neoplasm.